The normal level of human serum alcohol dehydrogenase (EC l.l.l.l) (ADH) activity which is not measurable by conventional methods was found to be within the range 0·07-0·56 VII when measured by a sensitive method based on a coenzyme recycling reaction. In different liver diseases the normal upper limit of serum ADH activity was found to be exceeded up to 70 times.
Although ADH activity under pathological conditions usually parallels that of other enzymes, e.g., sorbitol dehydrogenase (EC 1.l.l.l4) (SDH) and alanine transaminase (EC 2.6.1.2) (ALT), its relative elevation above the upper normal limit is generally greater, particularly in the early stages of viral hepatitis. Observations on some patients also suggested that very early stages of liver damage, caused by drugs or secondary malignancy, could be detected by increases of serum ADH activity when the activities of some other liver specific enzymes were still within their normal values.
A pilot experiment on rats, intoxicated with carbon tetrachloride, showed that serum ADH activity could reflect acute liver parenchymal damage more sensitively than SDH and ALT activity.
Alcohol dehydrogenase (alcohol: NAD+ oxidoreductase, Ee 1.1.1.1) (ADH) has broad substrate specificity-in man and is confined almost exclusively to the liver. From the data of Moser et al. 2 it can be calculated that only 5 %or less of the total activity is spread in other organs. Accordingly, ADH is a highly 'liver tissue specific' enzyme. 3 Since the majority of the total ADH content of liver cells was found in the cytosol;' it could be expected to leak out into the circulation after hepatocellular damage.
It has been known for a long time that ADH activity in serum from normals is undetectable, whereas some activity could be detected in liver diseases." The relative insensitivity of the conventional ADH assay method," which is based on optical measurement of the rate ofNADH formation, is inherent in the enzyme and is related primarily to its low molecular activity.' It was this that prevented the ADH assay from becoming one of the biochemical parameters of liver function. Recently, the semisynthetic thio-analogue ofNAD+ was suggested" for routine ADH activity measurements. With this modified coenzyme, ADH exhibits considerably higher activity towards ethanol than with NAD+. Also, performing the conventional ADH assay at tPennanent address: Department of Biochemistry, Faculty of Science, University J. E. Purkyne, Brno, Czechoslovakia. elevated temperatures? enhances the activity of minute amounts of the enzyme normally present in serum to a detectable level. In this study, we tried to examine the usefulness for clinical practice of another sensitive method" for ADH activity determination.
The method is based on a coupled reaction in which the enzyme is offered two substrates at once. The first one, n-butanol, is oxidised, and the second one (artificial aldehyde-like substrate) p-nitroso -N, N-dimethyl aniline (NDMA) is reduced, while the coenzyme recycles between its oxidised and reduced states. This recycling prevents the coenzyme from dissociating from the apoenzyme. By this manipulation of the kinetic pattern, molecular activity of the enzyme is enhanced approximately five times, which constitutes one of the factors of the increased sensitivity of this method. The other factor is the very intense yellow colour of NDMA. Fading of this colour in the assay mixture indicates NDMA reduction rate which, in turn, is the measure of ADH activity.
The molar absorption coefficient ofNDMA § at its absorption maximum (440 nm), being almost six times higher than that of NADH (at 340 nm), §While N-nitrosoderivatives are well-known carcinogens there are no available data on this sort of danger in the case of NOMA, which is a C-nitrosocompound (NOMA is an intermediary in the manufacture of certain dyes).
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makes the photometric response in the new method" correspondingly higher. Besides an approximately 30 times increase in sensitivity, the method is strictly specific for ADH, the other NADHproducing enzymes present in serum not interfering at all."
Simple modification of the test procedure (using pyrazole as an inhibitor to stop the enzymic reaction) allows the detection of the 'pyrazole insensitive portion' of the total ADH activity in some samples. This has been discussed elsewhere,"
The aim of the present study was to test on a randomly chosen group of in-patients whether serum ADH activity, measured by the recycling method," could give reasonable, clinically useful information about the diseased liver. For comparison with sick individuals, the normal range of serum ADH activity was determined. In patients, the relation of ADH activity to the clinical status and to three biochemical parameters, serum sorbitol dehydrogenase, EC 1.1.1.14 (SDH), and serum transaminases, EC 2.6.1.1 (AST) and EC 2.6.1.2 (ALT), characterising the conditions of the liver, was tested. A model experiment on rats was performed to examine the response of serum enzyme activities to the acute damage induced by carbon tetrachloride, a classical hepatotoxic (and nephrotoxic) agent.
Material NORMAL GROUP
A group of 70 clinically healthy persons (46 males, 24 females) with ages ranging from 16 to 66 years were donors of the sera used to determine normal ADH activity limits. Their serum enzyme activities of SDH, AST, and ALT, as well as the normal electrophoretic pattern of serum proteins, confirmed that they had normally functioning livers.
PATIENT GROUP
The group consisted of 143 in-patients (69 males and 74 females, age range 17-75 years) with different liver diseases. They were divided according to diagnosis into six subgroups: liver cirrhosis (28 cases), hepatomegaly of unrelated cause (26 cases), viral hepatitis at residual stage (17 cases), acute viral hepatitis (15 cases), various other liver diseases (36 cases), and miscellaneous secondaries (secondary liver diseases (21 cases)). Serum activities of ADH, SDH, AST, and ALT in each case were examined in the light of the diagnosis and clinical status as established by means of clinical and laboratory investigations.
Only one serum sample was available for examination in 60 of the cases. From the others, two or more samples were examined at various intervals. In cases Khayrollah, Al-Tamer, Taka, and Skursky of acute viral hepatitis, it was possible to follow up the course of the disease by several consecutive examinations during one month.
EXPERIMENT AL ANIMALS
Male Wistar rats (300-500 g body weight) were kept under hygienic conditions on a standard laboratory diet. Blood was withdrawn by cardiac puncture under light ether anaesthesia'? and the enzyme activities were determined the same day. One of the groups (20 animals) was used to determine the average enzyme activities and it served as a control.
The other four groups (20 animals each) were intoxicated by carbon tetrachloride. It was administered by intraperitoneal injection of 0'25 ml of a mixture of CC1 4 and olive oil (1:3 vjv) per 100 g body weight'! and the blood was withdrawn at different intervals, as shown in Fig. 5 , which includes data on animals that survived the intoxication.
CHEMICALS
All the chemicals used were of AR quality.
Methods of enzyme activity determination ADH ACTIVITY
Semimicro spectrophotometric cuvettes (light path 10 mm) were used, and the test was performed at 25°C on a Unicam SP 1800 Ultraviolet Spectrophotometer with Unicam AR 25 Recorder at a highly expanded scale range (0-2 absorbance unit per scale). Sample cuvettes contained 0·5 ml of the reaction mixture consisting of NOMA (30 !Lmol/l) and NAD (0'3 mmolfl) in 0·1 mol/l sodium phosphate buffer (pH 8'5) and 0·5 ml of serum sample. Absorbance in this cuvette at 440 run was not higher than 1· 5 (not to exceed the sensitivity limits of the instrument); otherwise serum was diluted (especially when it contained a high amount of bilirubin). Reference cuvettes contained only a NOMA solution of appropriate concentration and brought the initial absorbance of the sample cuvettes within the limit of ± 0·05 absorbance unit.
The base line was recorded for 1-2 minutes and the coupled enzymic reaction of NDMA reduction was started by the addition of 100 !Ll of aqueous n-butanol (20 mmoljl). After recording the reaction rate (which was virtually constant) for 1-2 minutes, all the enzymic NOMA reduction was stopped by the addition of 50 !LI J-phenanthroline solution (14 mrnol/l), Small reaction rates, persisting in some cases, were considered as non-enzymic (eg, by glutathione) and were subtracted. The slope of the base line (if any) is due either to the same cause or to the presence of endogenous substrate (ethanol or Results and discussion SDH ACTIVITY This was measured in fresh serum by the method described by Rose and Henderson.P the value of The distribution of all the values of ADH activity found in our healthy subjects, presented in Fig. 1 , does not contradict the log-Gaussian distribution found in the study cited above.P No significant differences between the sexes and six age groups were found by the two-way analysis of'variance.P But since the normal value is based on a comparatively small population sample, with unequal numbers of men and women and also an unbalanced age distribution (50% of the total healthy subjects were aged between 20 and 29 years), one cannot definitely exclude age and sex factors.
Examination of the correlation of ADH activity with other enzymes revealed that serum AOH activities correlated with the respective ALT values ( Fig. 2 ; correlation coefficient r=0'50) while there were no significant correlations with AST and SOH.
Lack of correlation between ADH and SOH activities seems somewhat surprising since both are liver-tissue specific enzymes. This might be due to one or more of the following factors: the serum enzymes originate also from sources other than liver; natural biological variations; different membrane permeability for various enzymes in the same organ (liver); technical limitation of the sensitivity of each method so that experimental errors could mask possibly existing correlations.
Stability of ADH activity
Storage of the sera for 48 hours at 4 DC caused approximately 10% loss of the total activity, while at ODC the loss was within the limits of reproducibility. Freezing and one thawing brings about at least a 10% loss. Since the 'pyrazole insensitive portion" of the total ADH activity is less stable, routine measurements were always performed on fresh serum whenever possible.
Precision of the method was tested three times using pooled normal and pathological human sera and (in terms of coefficient of variation) found to be 4'3%, 5,2%, and 7'2% (for n=5, 6, and 6, respectively). These results agree well with the reproducibility ofthe method reported previously. 812
NORMAL VALUES OF ADH ACTIVITY IN SERA OF HEALTHY INDIVIDUALS
From our normal population group, the lowest value was 0·07 and the highest was 0'56 V/I. Calculation using 2· 5 and 97· 5 percentile points 11i rendered 0·50 V/I as the upper normal limit. This figure is in good agreement with 0·56 V/l obtained by the European authors.P in spite of the geographical and racial differences of the populations studied. So one In comparison with SDH, which is considered to be of good 'liver-tissue specificity, '13ADH seems to be superior; while SDH activity was within normal limits in 51·2 % of the pathological sera, ADH activity was normal in only 36·4% of them. This seems to indicate that ADH is a relatively more specific indicator of hepatic injury and gave fewer falsely negative results than SDH.
This sort of crude comparison over the whole, biologically heterogeneous group seems to indicate that serum ADH activity might be able to reflect liver damage more sensitively than the other enzymes, and it may serve as a useful biochemical parameter in the assessment of liver functions. This is now examined.
MUTUAL RELATIONS OF ENZYME ACTIVITIES

Correlations ofA DH activity with that of other enzymes in the heterogeneous pathological group
Graphical tests (scatter graphs) showed that ADH activities in the sera of patients (unlike those of healthy individuals) were well associated with those of other enzymes. This is essentially in accord with the study of Kover et al.,12 although the set of enzymes they studied did not include SDH, and the group tested for correlations included persons with healthy livers (probably hospitalised or medically treated for other reasons).
The correlation of ADH with other enzyme activities would hardly justify introducing this new test into routine use. Poor correlations might, however, indicate a possible value for the test in differential diagnosis. In 15%of all the pathological cases, ADH was markedly elevated, and the majority of these were cases of viral hepatitis which further justifies the attention given to this disease (see below).
Relative differences among ADH and other activities within the pathological subgroups
The Table summarises the results of all enzyme   39 activities found in the subgroups of patients. Testing these results by the Wilcoxon matched-pairs signed-ranks testIS revealed no significant difference between the subgroups. This is not unexpected owing to the inevitable biological heterogeneity within the subgroups due to various disease stages. Two observation can, however, be made: (a) Cirrhotics showed the lowest mean ADHactivities (Table) . Low enzyme activities have been reported'? both in the affected liver and in sera of patients with liver cirrhosis. It appears justified to speculate that, in the protracted chronic disease, ADH might have leaked out to the circulation during the process of gradual reduction of the functional liver mass. One could not expect high serum ADH activities in cases of later stages of cirrhosis, especially if the rate of ADH degradation in blood was comparatively fast. The initial burst and subsequent rapid disappearance of ADH from the sera of cases of viral hepatitis (Fig. 4) seem to indicate a shorter half-life than that of ALT, which is known-" to be long. Three patients with acute exacerbations of chronic cirrhosis (included in the subgroup of various liver diseases) showed an elevated level of ADH (up to 16 times its upper normal limit) while other activities were markedly less elevated. (b) The levels of ALT in subgroups 3 and 4 (Table) are comparatively high, although, as has been mentioned above, they are not statistically significantly higher than the others. One could, perhaps, once more remember the half-life of ALT, which is approximately three times longer than that of AST.18 If the half-life of ADH is comparatively short (as this study seems to indicate), the ratio of ADH and ALT values in subgroups 3 and 4 in the Table suggest that, in the early stages of hepatocellular damage of any cause, serum ADH activity responds faster and more vigorously than ALT.
ENZYME ACTIVITIES DURING THE COURSE OF ACUTE VIRAL HEPATITIS
In our study we had the opportunity to measure, Healthy individuals 70 0·50 ± 0·03 0·97 ± 0·04 0·60 ± 0·04 0·54 ± 0·02 Figures are multiples of the upper normal values: 0·5, 3·0, 15·0, and 20·0 Ujl for ADH, SDH, ALT, and AST, respectively.
Means of enzyme activities in patient subgroups in comparison with normal group (who served to establish the ADH activity normal range)
Fig. 4
Means ofserum enzyme activities ofpatients with viral hepatitis measured at indicated intervals. Statistical evaluation of all the results indicated that the differences shown at intervals of3,7, and 9 days were highly significant (p<O'Ol) by Friedman two-way analysis ofvarianceP though not regularly, enzyme activities in the sera of patients with viral hepatitis several times during a period of four weeks. The results showed that ADH activity rose steeply, reaching the peak approximately one week after the onset of the disease (Fig. 4) . The peak ADH activity was higher than that of other enzymes. In some individual cases (not included in this series because they were tested fewer times than the cases in the longitudinal observation), it reached up to 70 times its upper normal limit while the activities of other enzymes never exceeded 50 times their normal limits. Viral hepatitis is infectious during the prodromal phase and in the early stages of jaundice. So the detection of the disease in this phase is of great importance. Since ADH activity is significantly different from other activities during the early stage of the disease, it appears to be of diagnostic value.
With the progress of the disease (Fig. 4 ) ADH activity decreased more rapidly than that of the other enzymes. No significant differences were seen between the activities in terms of the mean at these later stages. However, three cases classified as of a 'residual stage' (subgroup 4 in Table) , according to the duration the disease and almost normal levels of the other three enzyme activities, could have been considered as recovering. Their ADH activity was remarkably high (7-8 times the upper normal limit) and may indicate that a sort of relapse was occurring. Normally, on average (see Fig. 4 ) one month after the onset of viral hepatitis, the activities were slightly above their normal limits and again ADH was the highest in the pattern.
INDIVIDUAL PATHOLOGICAL CASES
Within the group of patients and in the subgroup of miscellaneous 'secondary liver diseases' (which was biologically too heterogeneous to be included in the Table) , 14 cases with distinctly increased ADH activity and with normal or less increased activities of other enzymes seemed interesting enough to be mentioned briefly although definite conclusions can not be reached. (normal up to 5~-:;), reflecting an impairment of one of the liver functions. This impairment was confirmed only by the ADH activity level in serum (which reached up to six times the upper normal limit) while the transaminases were normal and SDH activity reached only 1. 5 times its normal upper limit. It is possible that the elevated ADH activity is due to enzyme induction. For rats, increased levels of ADH in both liver and serum have been described owing to enzyme induction upon prolonged ethanol administration.P (b) In a case of primary liver carcinoma, six consecutive examinations of serum enzymes during the period of 16 days showed that ADH was permanently two to four times higher than the other three enzymes. (c) In three cases of liver metastases, 10 serial enzyme measurements were performed during 10 days and the activity of ADH was at least two to four times higher than that of all the other enzymes which were only slightly elevated. (d) In three cases, all clinical data indicated that they were caused by prolonged medication by either antituberculosis drugs (one case of TB meningitis, one of pulmonary tuberculosis) or corticosteroids and tranquilisers (one case of psoriasis). In the two former cases, the elevation of ADH activity was two to three times higher than that of the other three enzymes; in the latter case the ADH was the only one elevated (three times the upper limit) and hepatomegaly was the only other pronounced symptom. Serum ADH activity might therefore be useful as a screening test for liver dysfunction in assessing hepatotoxicity of drugs. In fact, among the subgroup of hepatomegaly of unrelated cause 12 cases were observed with markedly or even prominently increased ADH while the other three enzymes did not indicate any or only negligible elevation (although this is not evident from the Table) .
Whenever possible, frequent measurements of the enzyme activities were conducted, and it was observed that, during the medical control, ADH activities of some of the cases decreased gradually, probably due to the treatment. (e) Markedly higher activities of ADH than of the other enzymes were also observed in two cases of chronic hepatitis, and a similar pattern was seen in chronic cholecystitis, brucellosis, and amoebic hepatitis (one case each).
Together those results on individual cases seem to support the view that increased serum ADH activity could be used as an indicator reflecting sensitively, though not selectively, the degree of hepatocellular damage, whether due to infection, drug toxicity, inflammation or even malignancy.
The experiment on animals confirmed the conclusion that ADH could be of use in reliably pinpointing liver damage. Although the level of serum ADH activity does not give precise information on the cause of liver damage, our results agree with the previous observation of Mezey et al. 2o that serum ADH levels may help in differentiating between extra-and intra-hepatic cholestasis. These authors (using a relatively insensitive method) were not able to detect serum ADH activity in cases of jaundice if the cholestasis was extrahepatic, while in cases of intrahepatic cholestasis associated with cell necrosis, ADH was frequently detectable even though the transaminase levels were within the normal range. In our cases, 14 patients were suffering from cholestasis, clinically diagnosed as extrahepatic; ADH activity was within the normal range, while in 20 patients suffering from intrahepatic cholestasis, ADH activity was elevated, frequently more significantly than other liver enzyme activities.
EXPERIMENTAL INTOXICATION OF RATS DY CARD ON TETRACHLORIDE CCI 4 , a classical hepatotoxic agent, was used to test the response of serum ADH activity in comparison with two other enzymes (SDH and ALT) as an indicator of liver cell damage. Although the damage caused to individual animals by the intraperitoneal injection of the poison was probably not uniform enough (causing considerable scatter of the values), the results (Fig. 5 ) indicated that the relative increase in ADH activity was more significant than that of the two other enzymes. AST activity measurement was not included because its level could be changed due to the heart puncture. (The mean values of enzyme activities, unlike in human subjects, were used for comparison because of the lack of reliable data on the upper limits of the enzyme activities in animals.) 
